E. Thomas Corcoran
CIK: 0001191763
Transaction Breakdown
Open Market Buys (P)3 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PAHC
PHIBRO ANIMAL HEALTH CORP
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 29, 2026PAHC
PHIBRO ANIMAL HEALTH CORP
Purchase(P)Direct10K shares at avg. $31.77$318K - Feb 24, 2025PAHC
PHIBRO ANIMAL HEALTH CORP
Purchase(P)Direct5K shares at avg. $22.10$111K - Sep 4, 2024PAHC
PHIBRO ANIMAL HEALTH CORP
Purchase(P)Direct5K shares at avg. $20.02$100K
1-3 of 3 transactions
About CORCORAN E THOMAS
CORCORAN E THOMAS (SEC CIK 0001191763) files insider reports with the SEC as Director of PHIBRO ANIMAL HEALTH CORP (PAHC).
Signal8 holds 3 ownership filings by CORCORAN E THOMAS, all Form 4s, filed between Sep 6, 2024 and Jun 2, 2026. Those filings report 3 transactions, from Sep 4, 2024 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CORCORAN E THOMAS's filings is in TEANECK, NJ.
Recent filings by CORCORAN E THOMAS
Other insiders filing for PHIBRO ANIMAL HEALTH CORP (PAHC)
- David Glenn, Chief Financial Officer
- Miller Larry Lee, Chief Operating Officer
- Rodriguez Patrick, VP Finance and Treasurer
- BENDHEIM Jonathan, Director
- Weinstein Judith
- BENDHEIM JACK, Executive Chairman